Cancer Treatment News and Research

RSS

NGOC to share expertise with United Network of US Oncology

Northwest Georgia Oncology Centers, a medical practice dedicated to delivering high quality, cost-effective oncology and hematology services to patients in Northwest Georgia, and US Oncology, Inc., the nation's leading integrated oncology company, announced today that NGOC has joined the United Network of US Oncology. The practice, which remains independently owned by its physicians, now has expanded resources from a nationwide network of physicians and clinicians who collaborate to enhance the science and delivery of cancer care.

15 Jul 2010

Highlights of AAPM 52nd meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July 18 - 22, 2010 in Philadelphia, PA.

14 Jul 2010

Stanford Hospital and Clinics completes migration to InterSystems Ensemble platform

InterSystems Corporation today highlighted the successful completion of an enterprise-scale integration initiative at Stanford Hospital and Clinics (SHC). With the migration from legacy integration software to the InterSystems Ensemble® rapid integration and development platform, SHC is now processing more than 2.2 million HL7 messaging transactions on a daily basis.

13 Jul 2010

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.

12 Jul 2010

Concord Medical announces joint venture with Chang'An Hospital for operation of cancer treatment facilities

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that effective as of July 1, 2010 it has entered into a joint venture with Chang'An Hospital for the operation of Chang'An Hospital's cancer treatment facilities by acquiring a 52% equity interest in Xi'an Wan Jie Hua Xiang Medical Technology Development Limited.

12 Jul 2010

Reducing chronic pain, dry mouth could improve quality of life in head and neck cancer patients: Study

Head and neck cancer patients who reported poor sleep quality one year after diagnosis had more symptoms of chronic pain and complaints of dry mouth related to radiation treatments, according to a recent study from the University of Michigan Comprehensive Cancer Center.

12 Jul 2010

Vanderbilt Medical Center treats first patient in Galil Medical's new TRACE renal registry

Galil Medical, a global leader in minimally invasive cryotherapy cancer treatments, today announced that Vanderbilt University Medical Center in Nashville, Tenn., has treated the first patient to be included in its new patient registry.

12 Jul 2010

Skandion Clinic selects IBA for installation of particle therapy facility

IBA (Ion Beam Applications S.A.) announced that Skandion Clinic, the clinical centre for proton therapy in Sweden, has selected IBA for the installation of a particle therapy facility. This new center will be managed by a consortium of seven Swedish counties, representing eight university hospitals.

9 Jul 2010

Roxane announces FDA approval for Anastrozole Tablets ANDA

Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1mg by the U.S. Food and Drug Administration. The product is available in bottles of 30 for immediate shipment to wholesalers and pharmacies nationwide.

9 Jul 2010

Patients are not presented with information about prostate cancer treatment options: Urologists

At the recent meeting of the American Urological Association in San Francisco, researchers presented studies regarding the decision making process men go through when considering proposed prostate cancer treatments. Dr. Vorstman, renowned Florida urologist, believes these studies would have more meaning if patients were presented with information about prostate cancer treatment options in a different fashion.

7 Jul 2010

VA addresses health concerns including possible HIV exposure and Veterans' general poor health

"The Democratic chairman of the House Veterans Affairs Committee lambasted the Obama administration over its handling of an incident at a St. Louis VA center in which more than 1,800 veterans were told they may have been exposed to HIV. ... The Department of Veterans Affairs last month sent a letter to 1,812 patients informing them that could have been exposed to HIV and other deadly viruses because of dental equipment that was insufficiently sterilized over a period of 13 months."

7 Jul 2010

Scientists discover nanoparticle to deliver DNA with minimum toxic effect

In lab experiments, the researchers have found that this device, a vector, is able to deliver DNA deeply enough into a cell to allow genetic material to be activated - a critical step in gene therapy. This vector is between 2 - and 10 times more effective than other experimental materials, according to the research.

7 Jul 2010

Novel therapy slows tumor growth in 85% of advanced breast cancer patients: Study

A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study, researchers report in the July 6 issue of The Lancet.

6 Jul 2010

American College of Surgeons CoC launches national pilot study for ProvenCare Lung Cancer Collaborative

A national pilot study that will promote evidence-based evaluation and treatment standards for patients with resectable non small cell lung cancer (NSCLC) was launched yesterday by the Commission on Cancer (CoC) of the American College of Surgeons.

3 Jul 2010

MabCent finds extraordinary life forms in the Arctic

During its short existence the Centre on Marine Bioactives and Drug Discovery (MabCent) in Tromsø has analysed some 70,000 fractions of Arctic marine organisms. Patents on two molecules have been applied for and applications for another 20 will soon follow.

3 Jul 2010

Florida Biomedical Research Program awards $2M in grants to Scripps Research Institute scientists

The Florida Biomedical Research Program has awarded $2 million in biomedical research grants to three scientists from the Florida campus of The Scripps Research Institute.

1 Jul 2010

EMA grants Scientific Advice to Aeterna Zentaris for Phase 3 trial of anticancer compound perifosine

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer.

30 Jun 2010

Mayo Clinic biostatistician become director of CALGB

In a move that will improve efficiency and collaboration in cancer research, Mayo biostatistician Daniel Sargent, Ph.D., will become director of the Statistical Center for the Cancer and Leukemia Group B (CALGB), a national association of cancer researchers funded primarily by the National Cancer Institute (NCI).

30 Jun 2010

Ovarian transplant procedure increases lifespan, restores fertility in aging mice

Scientists have discovered that when they transplant ovaries from young mice into aging female mice, not only does the procedure make the mice fertile again, but also it rejuvenates their behaviour and increases their lifespan. The question now is: could ovarian transplants in women have the same effect?

29 Jun 2010

Aeterna Zentaris receives positive Scientific Advice from EMA for perifosine Phase 3 trial in colorectal cancer

29 Jun 2010

Cancer Treatment News and Research

NGOC to share expertise with United Network of US Oncology

Highlights of AAPM 52nd meeting

Stanford Hospital and Clinics completes migration to InterSystems Ensemble platform

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Concord Medical announces joint venture with Chang'An Hospital for operation of cancer treatment facilities

Reducing chronic pain, dry mouth could improve quality of life in head and neck cancer patients: Study

Vanderbilt Medical Center treats first patient in Galil Medical's new TRACE renal registry

Skandion Clinic selects IBA for installation of particle therapy facility

Roxane announces FDA approval for Anastrozole Tablets ANDA

Patients are not presented with information about prostate cancer treatment options: Urologists

VA addresses health concerns including possible HIV exposure and Veterans' general poor health

Scientists discover nanoparticle to deliver DNA with minimum toxic effect

Novel therapy slows tumor growth in 85% of advanced breast cancer patients: Study

American College of Surgeons CoC launches national pilot study for ProvenCare Lung Cancer Collaborative

MabCent finds extraordinary life forms in the Arctic

Florida Biomedical Research Program awards $2M in grants to Scripps Research Institute scientists

EMA grants Scientific Advice to Aeterna Zentaris for Phase 3 trial of anticancer compound perifosine

Mayo Clinic biostatistician become director of CALGB

Ovarian transplant procedure increases lifespan, restores fertility in aging mice

Aeterna Zentaris receives positive Scientific Advice from EMA for perifosine Phase 3 trial in colorectal cancer

Cancer Research eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News